These Healthcare stocks are trading higher:
-Surrozen Inc (SRZN) stock is trading at $10.50, an increase of $3.26, or 44.89%, on high volume. Consonance-Hfw Acq Corp gets a Sentiment Score of Bearish from InvestorsObserver.
-ZIOPHARM Oncology Inc. (ZIOP) stock is trading at $2.17, a rise of $0.53, or 34.24%, on high volume. Ziopharm Oncology IN gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $4.00.
-Adaptimmune Therapeutics PLC - ADR (ADAP) stock is trading at $6.23, a rise of $1.28, or 24.89%, on high volume. Adaptimmune Ther ADR gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $8.67.
-Clover Health Investments Corp (CLOV) stock is trading at $10.67, a gain of $1.83, or 20.95%, on high volume. Clover Health Investments Corp gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Hold with a price target of $9.67.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Sharecare Inc (SHCR) stock is trading at $7.02, a drop of $2.13, or 23.39%, on high volume. Sharecare Inc Cl A gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $13.00.-CorMedix Inc. (CRMD) stock is trading at $5.02, a loss of $1.44, or 22.45%, on high volume. Cormedix Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $22.00.
-Celularity Inc (CELU) stock is trading at $7.06, a drop of $1.64, or 18.91%, on moderate volume. Celularity Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $16.00.
-Forte Biosciences Inc (FBRX) stock is trading at $4.32, a decline of $0.74, or 14.72%, on high volume. Forte Biosciences Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $86.00.
